Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tursz

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|July 3, 2004
Cancer funding throughout the worldMark McCarthy, Roy M Poses, Mahasti Saghatchian, et al.
Acta Oncologica (Stockholm, Sweden)|October 19, 2007
An unusual variant of diffuse retinoblastoma in an adultKaouthar Khanfir, Agnes Chompret, Eric Frau, et al.
Cancer Research|February 11, 2010
Dendritic cell-derived exosomes for cancer immunotherapy: what's next?Sophie Viaud, Clotilde Théry, Stéphanie Ploix, et al.
Gastroenterology|December 31, 2003
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumorAgnès Chompret, Caroline Kannengiesser, Michel Barrois, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 6, 2003
Combined effects of docetaxel and angiostatin gene therapy in prostate tumor modelAriane Galaup, Paule Opolon, Céline Bouquet, et al.
The Lancet. Oncology|December 10, 2003
Throwing a wrench in the works?Françoise Meunier, Nathalie Dubois, Anastassia Negrouk, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancerRodrigo Arriagada, Marc Spielmann, Serge Koscielny, et al.
Cancer Research|February 7, 2007
Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cellsEvelyn Ullrich, Mathieu Bonmort, Grégoire Mignot, et al.
Tumori|June 21, 2008
Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI)Mahasti Saghatchian, Henk Hummel, Renée Otter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|July 3, 2004
Cancer funding throughout the worldMark McCarthy, Roy M Poses, Mahasti Saghatchian, et al.
Acta Oncologica (Stockholm, Sweden)|October 19, 2007
An unusual variant of diffuse retinoblastoma in an adultKaouthar Khanfir, Agnes Chompret, Eric Frau, et al.
Cancer Research|February 11, 2010
Dendritic cell-derived exosomes for cancer immunotherapy: what's next?Sophie Viaud, Clotilde Théry, Stéphanie Ploix, et al.
Gastroenterology|December 31, 2003
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumorAgnès Chompret, Caroline Kannengiesser, Michel Barrois, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 6, 2003
Combined effects of docetaxel and angiostatin gene therapy in prostate tumor modelAriane Galaup, Paule Opolon, Céline Bouquet, et al.
The Lancet. Oncology|December 10, 2003
Throwing a wrench in the works?Françoise Meunier, Nathalie Dubois, Anastassia Negrouk, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancerRodrigo Arriagada, Marc Spielmann, Serge Koscielny, et al.
Cancer Research|February 7, 2007
Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cellsEvelyn Ullrich, Mathieu Bonmort, Grégoire Mignot, et al.
Tumori|June 21, 2008
Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI)Mahasti Saghatchian, Henk Hummel, Renée Otter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Pageof 5